Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells
Clinical trial NCT00799799 · UNKNOWN
Trial details
- NCT number
- NCT00799799
- Sponsor
- University of Bologna
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2009-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.